Julphar Bangladesh, a subsidiary of the Ras Al Khaimah-based Julphar Gulf Pharmaceutical Industries, has signed a strategic toll agreement with the Bangladeshi non-profit company SMC Enterprise Limited (SMC) to manufacture pharmaceutical products.

The agreement was signed at the SMC head office in Dhaka, Bangladesh, on May 4, said a statement from the company.

Under the terms of the toll manufacturing contract signed by Sudhir Kumar Sinha, group general manager of Julphar Bangladesh and Ali Reza Khan, managing director of SMC, the company will manufacture pharmaceutical products of all dosage forms for SMC, it added.

Julphar Bangladesh’s Sinha, said: “The partnership will enable our company to grab rural market shares and address major needs for the Bangladeshi families.”

“It will enhance the Julphar brand and, by giving access to high quality products to a wider range of the Bangladeshi population, it will sustain a healthy community within the country,” he said.

“This initiative is consistent with the company’s vision of sustainable health and with our mission to expand our offerings of medicines to patients beyond the Middle East and Africa region,” he added. – TradeArabia News Service